CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Cooper outlines Q4 2026 EPS of $1.05-$1.09 while completing strategic review and adding $1B to buyback authorization

EarningsPositive
AI Analysis

Summary

Cooper Companies provided Q4 2026 EPS guidance of $1.05-$1.09 while completing a strategic review and increasing share buyback authorization by $1 billion.

Financial Highlights

EPS

$1.05-$1.09

Guidance

Q4 2026 EPS guidance of $1.05-$1.09

Importance:4/10
Sentiment:
0.30
Earnings GuidanceShare BuybackStrategic Review
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on September 10, 2026 2:37 AM

Read Original